CHAPEL END SURGERY — All Prescriptions & Medications — Page 9
Practice Code: M84005 | NUNEATON, CV10 0JH
Showing results 401-450 of 482
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Testosterone | 14 | 840 | £381 | -81.7% ▼ |
| Other calcium supplement preparations | 14 | 1,540 | £690 | +86.7% ▲ |
| Ciclosporin (Eye Anti Inflammatory) | 14 | 420 | £1.0K | -43.5% ▼ |
| Brinzolamide and timolol | 14 | 70 | £94 | -63.0% ▼ |
| 14 | 127 | £120 | -56.7% ▼ | |
| 14 | 275 | £29 | -53.1% ▼ | |
| 14 | 840 | £1.5K | -71.3% ▼ | |
| 14 | 1,210 | £206 | -55.9% ▼ | |
| Glycopyrronium bromide | 13 | 1,092 | £7.6K | -36.7% ▼ |
| Sennosides | 13 | 3,900 | £74 | -57.9% ▼ |
| Methyldopa | 13 | 784 | £160 | -23.7% ▼ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 13 | 364 | £209 | -17.8% ▼ |
| Naftidrofuryl oxalate | 13 | 2,520 | £278 | -60.1% ▼ |
| Fluvastatin sodium | 13 | 364 | £51 | -43.8% ▼ |
| Nitrazepam | 13 | 364 | £19 | -75.0% ▼ |
| Haloperidol | 13 | 791 | £370 | -72.7% ▼ |
| Valproic acid | 13 | 1,170 | £211 | -85.1% ▼ |
| Atomoxetine hydrochloride | 13 | 364 | £893 | -61.6% ▼ |
| Aspirin | 13 | 200 | £6 | +32.3% ▲ |
| Rufinamide | 13 | 2,912 | £4.7K | -24.3% ▼ |
| Pramipexole | 13 | 390 | £58 | -86.8% ▼ |
| Testosterone undecanoate | 13 | 13 | £1.1K | -48.8% ▼ |
| Fesoterodine fumarate | 13 | 364 | £31 | -67.0% ▼ |
| Methotrexate | 13 | 52 | £794 | -56.4% ▼ |
| Bicalutamide | 13 | 364 | £18 | -59.8% ▼ |
| RtS extensively hydrolysed formula, high energy (0913103) | 13 | 291.2K | £7.3K | +127.1% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 13 | 18.0K | £277 | -43.3% ▼ |
| Ciprofloxacin | 13 | 115 | £103 | +63.6% ▲ |
| Betamethasone sodium phosphate | 13 | 130 | £29 | -49.8% ▼ |
| Timolol and travoprost | 13 | 33 | £115 | -59.8% ▼ |
| 13 | 125 | £258 | -17.2% ▼ | |
| 13 | 1,560 | £5.0K | -42.0% ▼ | |
| 13 | 1,100 | £3.5K | -9.1% ▼ | |
| 13 | 1,050 | £3.5K | +52.0% ▲ | |
| 13 | 312 | £574 | -7.3% ▼ | |
| 13 | 380 | £2.3K | +13.0% ▲ | |
| Olsalazine sodium | 12 | 1,166 | £1.8K | +19.5% ▲ |
| Flecainide acetate | 12 | 720 | £22 | -84.6% ▼ |
| Olmesartan medoxomil/hydrochlorothiazide | 12 | 336 | £148 | +21.0% ▲ |
| Desloratadine | 12 | 360 | £32 | -58.4% ▼ |
| Hyoscine hydrobromide | 12 | 668 | £107 | -64.9% ▼ |
| Tapentadol | 12 | 672 | £897 | -70.9% ▼ |
| Propylthiouracil | 12 | 1,068 | £147 | -4.5% ▼ |
| Goserelin acetate | 12 | 12 | £2.6K | -72.8% ▼ |
| Pyridostigmine bromide | 12 | 2,400 | £196 | -29.9% ▼ |
| Olopatadine | 12 | 110 | £98 | -72.6% ▼ |
| Travoprost | 12 | 30 | £19 | -74.5% ▼ |
| Zinc oxide | 12 | 720 | £38 | -40.3% ▼ |
| Clindamycin phosphate | 12 | 420 | £95 | -27.0% ▼ |
| 12 | 212 | £52 | -69.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.